Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8327462 | 0.77 | TSHR (0.39) | ALDH1A1TSHRPKMGAAKDM4E | |
| SCHEMBL8329568 | 0.74 | KDM4E (0.39) | TSHRPKMKDM4EHTTIDO1 | |
| SCHEMBL8329614 | 0.71 | ALDH1A1 (0.36) | ALDH1A1TSHRPKMGAAKDM4E | |
| SCHEMBL15358480 | 0.69 | ESR1 (0.54) | ALDH1A1TSHRPKMGAA | |
| SCHEMBL4639146 | 0.65 | KMT2A (0.38) | ALDH1A1PKMKDM4ELMNAMEN1 | |
| SCHEMBL9130426 | 0.64 | IDO1 (0.47) | ALDH1A1TSHRPKMGAASMN1; SMN2 | |
| SCHEMBL30669346 | 0.61 | SMN1; SMN2 (0.60) | ALDH1A1TSHRPKMGAAKDM4E | |
| SCHEMBL30669409 | 0.61 | SMN1; SMN2 (0.60) | ALDH1A1TSHRPKMGAAKDM4E | |
| SCHEMBL11518221 | 0.61 | ALDH1A1 (0.52) | ALDH1A1TSHRPKMGAAKDM4E | |
| SCHEMBL27678037 | 0.61 | TSHR (0.59) | TSHRGAAKDM4ESMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0579797-B1 | DIPHOSPHINE LIGANDS | HOFFMANN LA ROCHE (CH) | 1999-04-21 | — | — | EP | claimed |
| EP-0579797-B1 | DIPHOSPHINE LIGANDS | HOFFMANN LA ROCHE (CH) | 1999-04-21 | — | — | EP | disclosed |
| EP-0509974-B1 | Pyrrolo[2,3-b]pyridines having therapeutic activity and a process for the preparation thereof | ASTRA AB (SE) | 1999-01-13 | — | — | EP | disclosed |
| US-5439917-A | Phenyl-pyrrolo(2,3-b)pyridine antisecretory agent of gastric acid; adenosine triphosphatase enzyme inhibitor | AKTIEBOLAGET ASTRA (SE) | 1995-08-08 | — | — | US | disclosed |
| EP-0580616-A1 | NEW ACTIVE COMPOUNDS | Astra Aktiebolag (SE) | 1994-02-02 | — | — | EP | disclosed |
| EP-0579797-A1 | DIPHOSPHINE LIGANDS | F. HOFFMANN-LA ROCHE AG (CH) | 1994-01-26 | — | — | EP | disclosed |
| WO-1993015091-A1 | DIPHOSPHINE LIGANDS | F. HOFFMANN-LA ROCHE AG (CH) | 1993-08-05 | — | — | WO | disclosed |
| CN-1067892-A | The preparation method of new pyrrolo-[2,3-b] pyridine derivate | ASTRA AB (SE) | 1993-01-13 | — | — | CN | disclosed |
| EP-0509974-A1 | Pyrrolo[2,3-b]pyridines having therapeutic activity and a process for the preparation thereof | Astra Aktiebolag (SE) | 1992-10-21 | — | — | EP | disclosed |
| WO-1992017477-A1 | NEW ACTIVE COMPOUNDS | AKTIEBOLAGET ASTRA (SE) | 1992-10-15 | — | — | WO | disclosed |